Prof.Uğur GEZER


Onkoloji Enstitüsü, Teşhis Tedavi Ve Bakım Hizmetleri

Temel Onkoloji Ana Bilim Dalı


Research Areas: Life Sciences, Molecular Biology and Genetics, Genetic Engineering, Moleculer Biology of Cancer, Natural Sciences


Names in Publications: Deligezer U, Deligezer , Ugur, Deligezer, U.

Metrics

Publication

137

Citation (WoS)

1678

H-Index (WoS)

20

Citation (Scopus)

1763

H-Index (Scopus)

22

Project

57

Thesis Advisory

5

Open Access

1
UN Sustainable Development Goals

Education Information

1996 - 2000

1996 - 2000

Doctorate

Ruprecht-Karls-Universitaet Heidelberg, Seyahat, Turizm Ve Eğlence Hizmetleri, Germany

1993 - 1996

1993 - 1996

Postgraduate

Universitaet Kaiserslautern, Biyoloji, Germany

1988 - 1992

1988 - 1992

Undergraduate

Hacettepe University, Fen Fakültesi, Turkey

Dissertations

2000

2000

Doctorate

Die Wechselwirkung von rekombinantem Hepatitis B Virus X-Protein mit kultivierten Zellen: Steuerung apoptotischer Prozesse Sustainable Development

Ruprecht-Karls-Universitaet Heidelberg, Alman Kanser Araştıma Merkezi, Tümör Virolojisi

1996

1996

Postgraduate

Untersuchung der Struktur einer instabilen Region im Chromosom von Streptomyces rimosus R6-501

Universitaet Kaiserslautern, Biyoloji, Genetik

Foreign Languages

B2 Upper Intermediate

B2 Upper Intermediate

English

C1 Advanced

C1 Advanced

German

Research Areas

Life Sciences

Molecular Biology and Genetics

Genetic Engineering

Moleculer Biology of Cancer

Natural Sciences

Academic Titles / Tasks

2012 - Continues

2012 - Continues

Professor

Istanbul University, Onkoloji Enstitüsü, Onkoloji

2007 - 2012

2007 - 2012

Associate Professor

Istanbul University, Onkoloji Enstitüsü, Onkoloji

2000 - 2007

2000 - 2007

Instructor

Istanbul University, Onkoloji Enstitüsü, Onkoloji

Managerial Experience

2009 - Continues

2009 - Continues

Head of Department

İstanbul Üniversitesi, Onkoloji Enstitüsü

Courses

Postgraduate

Postgraduate

İmmün Sistem Biyolojisi

Postgraduate

Postgraduate

Tümör İmmünolojisine Giriş

Postgraduate

Postgraduate

Temel İmmünoloji

Doctorate

Doctorate

Tümör İmmünolojisi

Postgraduate

Postgraduate

Kanser Biyolojisine Giriş

Published journal articles indexed by SCI, SSCI, and AHCI

2022

2022

The Utility of Repetitive Cell-Free DNA in Cancer Liquid Biopsies.

Gezer U., Bronkhorst A. J. , Holdenrieder S.

Diagnostics (Basel, Switzerland), vol.12, no.6, 2022 (SCI-Expanded) Sustainable Development identifier identifier identifier

2020

2020

Investigation of lncRNA H19 in prostate cancer cells and secreted exosomes upon androgen stimulation or androgen receptor blockage

ÖZGÜR E., GEZER U.

BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, vol.121, no.5, pp.362-365, 2020 (SCI-Expanded) Sustainable Development identifier identifier identifier

2019

2019

Enzalutamide restores the testosterone effect on H19 expression in prostate cancer cells but not in exosomes

ÖZGÜR E., GEZER U.

Turgut Özal Tıp Merkezi Dergisi (E.A İnönü Üniversitesi Tıp Fakültesi Dergisi), vol.26, pp.1056-1059, 2019 (SCI-Expanded) Sustainable Development

2016

2016

GAS5 oligonucleotides as therapeutic agents in breast cancer

Fayda M., Gezer U.

TRANSLATIONAL CANCER RESEARCH, vol.5, 2016 (SCI-Expanded) Sustainable Development identifier

2014

2014

Increased DNA Integrity in Colorectal Cancer

Leszinski G., LEHNER J., Gezer U., Holdenrieder S.

IN VIVO, vol.28, no.3, pp.299-303, 2014 (SCI-Expanded) Sustainable Development identifier identifier identifier

2014

2014

Investigation of circulating lncRNAs in B-cell neoplasms.

Isin M., Ozgur E., ÇETİN G., Erten N., Aktan M., Gezer U., et al.

Clinica chimica acta; international journal of clinical chemistry, vol.431, pp.255-9, 2014 (SCI-Expanded) identifier identifier identifier

2012

2012

Relevance of Histone Marks H3K9me3 and H4K20me3 in Cancer

Leszinski G., Gezer U., Siegele B., Stoetzer O., Holdenrieder S.

ANTICANCER RESEARCH, vol.32, no.5, pp.2199-2205, 2012 (Peer-Reviewed Journal) Sustainable Development identifier identifier identifier

2008

2008

Effect of adjuvant chemotherapy on integrity of free serum DNA in patients with breast cancer

Deligezer U., Eralp Y., Akisik E. Z. , Akisik E. E. , Saip P., Topuz E., et al.

CIRCULATING NUCLEIC ACIDS IN PLASMA AND SERUM V, vol.1137, pp.175-179, 2008 (SCI-Expanded) Sustainable Development identifier identifier identifier

2007

2007

Expression of the TRAIL receptors in blood mononuclear cells in leukemia.

GEZER U., DALAY M. N.

PATHOLOGY & ONCOLOGY RESEARCH, vol.13, no.4, pp.290-294, 2007 (SCI-Expanded)

2007

2007

Expression of the TRAIL receptors in blood mononuclear cells in leukemia

Deligezer U., Dalay N.

PATHOLOGY & ONCOLOGY RESEARCH, vol.13, no.4, pp.290-294, 2007 (SCI-Expanded) identifier identifier identifier

2006

2006

MTHFR C677T gene polymorphism in lymphoproliferative diseases

GEZER U., AKIŞIK E. E. , AĞAOĞLU F., ERTEN S. N. , DALAY M. N.

Journal of Clinical and Laboratory Medicine, vol.20, pp.37-41, 2006 (SCI-Expanded)

2006

2006

Methylation of the INK4A/ARF locus in blood mononuclear cells

Deligezer U., Erten N., Akisik E. E. , Dalay N.

ANNALS OF HEMATOLOGY, vol.85, no.2, pp.102-107, 2006 (SCI-Expanded) identifier identifier identifier

2006

2006

Methylation of the INK4A/ARF locus in blood mononuclear cells

GEZER U., Erten N., YÖRÜKER E. E. , DALAY M. N.

ANNALS OF HEMATOLOGY, vol.85, no.2, pp.102-7, 2006 (SCI-Expanded)

2006

2006

MTHFR C677T gene polymorphism in lymphoproliferative diseases

Deligezer U., Akisik E. E. , Yaman F., Erten N., Dalay N.

JOURNAL OF CLINICAL LABORATORY ANALYSIS, vol.20, no.2, pp.37-41, 2006 (SCI-Expanded) Sustainable Development identifier identifier identifier

2005

2005

Methylation of the INK4A/ARF locus in blood mononuclear cells

GEZER U., ERTEN S. N. , YÖRÜKER E. E. , DALAY M. N.

ANNALS OF HEMATOLOGY, vol.85, no.2, pp.102-107, 2005 (SCI-Expanded)

2004

2004

Association of the XRCC1 gene polymorphisms with cancer risk in Turkish breast cancer patients

Deligezer U., Dalay N.

EXPERIMENTAL AND MOLECULAR MEDICINE, vol.36, no.6, pp.572-575, 2004 (SCI-Expanded) Sustainable Development identifier identifier identifier

2004

2004

Association of the XRCC1 gene polymorphisms with cancer risk in Turkish breast cancer patients

GEZER U., DALAY M. N.

EXPERIMENTAL MOLECULAR MEDICINE, vol.36, no.6, pp.572-575, 2004 (SCI-Expanded) Sustainable Development

Articles Published in Other Journals

Refereed Congress / Symposium Publications in Proceedings

2020

2020

Investigation of miR-145 target genes in multiple myeloma cell lines

Kaya M., Suer İ., Karataş Ö. F. , Özgür E., Gezer U., Çefle K., et al.

V.Uluslararası Katılımlı Erciyes Tıp Genetik Günleri Kongresi, Nevşehir, Turkey, 20 - 22 February 2020, vol.2584, pp.37 Sustainable Development

2019

2019

Investigation of miR-34a target genes in multiple myeloma cell lines

Suer İ., Kaya M., Karataş Ö. F. , Özgür E., Gezer U., Çefle K., et al.

VII. International Congress of Molecular Medicine, İstanbul, Turkey, 5 - 07 September 2019, pp.141

2017

2017

Circulating H4K20me3 and SUV420H2 mRNA in blood plasma of patients with colorectal cancer

YORUKER E. E. , ÖZGÜR E., KESKİN M., GEZER U.

10th Internatioanl Syposium of Circulating Nucleic Acids in serum and Plasma, Montpellier, France, 20 - 22 September 2017, pp.32 Sustainable Development

2017

2017

PCA3 Suppresion Enhances The Effect of Androgen Receptor Inhibition in Prostate Cancer Cells.

ÖZGÜR E., GEZER U.

VI. International Congress of Molecular Medicine, İstanbul, Turkey, 22 May - 25 August 2017, pp.0-158 Sustainable Development

2017

2017

Is there a correlation between serum Epstein-Barr virus DNA level and tumor metabolic activity, TNM staging and tumor load in nasopharyngeal cancer patients?

Ahmedova A., Ozkaya B., Tambas M., Gezer U., Ozgur E., Sahin D., et al.

53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, Illinois, United States Of America, 2 - 07 June 2017, vol.35 Sustainable Development identifier

2017

2017

Treatment response and prognosis according to pre and post treatment Ebstein-Barr virus DNA level in nasopharyngeal carcinoma patients.

Ahmedova A., Ozkaya K., Tambas M., Gezer U., Ozgur E., Sahin D., et al.

53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, Illinois, United States Of America, 2 - 07 June 2017, vol.35 identifier

2016

2016

Evaluation of Circulating Long Non-Coding RNA H9 and Cell-free Nucleosomes in Plasma of Patients with Gastric Cancer

YÖRÜKER E. E. , KESKİN M., Koldemir O., KULLE C. B. , GEZER U.

The 43rd International Society of Oncology and Biomarkers Annual Congress, Chicago, United States Of America, 1 - 06 September 2016, pp.6 Sustainable Development

2015

2015

Increased DNA Integrity of Free Serum DNA in Patients with Colorectal Cancer

YÖRÜKER E. E. , ÖZGÜR E., KESKİN M., DALAY M. N. , GEZER U.

The 42nd Congress of the International Society of Oncology and Biomarkers, Zakopane, Poland, 3 - 07 October 2015, pp.50-51 Sustainable Development

2015

2015

Histone methylation marks in circulating nucleosomes as novel biomarker in colorectal cancer

GEZER U., YÖRÜKER E. E. , ÖZGÜR E., KESKİN M., Holdenrieder S.

IX. Circulating Nucleic Acids in Plasma and Serum, Berlin, Germany, 10 - 12 September 2015, pp.47 Sustainable Development

2014

2014

Circulating MicroRNA expression analysis in papillary thyroid carcinoma

YÖRÜKER E. E. , Terzioğlu D., TEKSÖZ S., USLU F. E. , GEZER U., DALAY M. N.

41 Congress of the International Society of Oncology and Biomarkers, Barselona, Spain, 15 - 18 March 2014, pp.27-28

2012

2012

Expression levels of circulating gas5 and lincrna-p21 in multiple myeloma

Isin M., Ozgur E., Erten N., Gezer U., Dalay N.

40th Congress of the International-Society-of-Oncology-and-Biomarkers, Jerusalem, Israel, 13 - 17 October 2012, vol.33, pp.111 identifier

2012

2012

High-throughput sequencing of H3K9me3-and H4K20me3-associated circulating nucleosomal DNA

Gezer U., Ustek D., Yoruker E. E. , Cakiris A., Abaci N., Leszinski G., et al.

40th Congress of the International-Society-of-Oncology-and-Biomarkers, Jerusalem, Israel, 13 - 17 October 2012, vol.33, pp.56 identifier

2011

2011

Characterization of H3K9me3- and H4K20me3-associated nucleosomal DNA by high-throughput sequencing in colorectal cancer

GEZER U., ÜSTEK D., AKIŞIK E. E. , ÇAKİRİS A., ABACI N., Holdenrieder S., et al.

7th International Conference on Circulating Nucleic Acids in Plasma and Serum, Spain, 1 - 04 October 2011, pp.19 Sustainable Development

2011

2011

Investigation of plasma lncRNA levels in chronic lymphocytic leukemia and multiple myeloma patients

IŞIN M., Özgür E., AKTAN M., ERTEN S. N. , GEZER U., DALAY M. N.

7th International Conference on Circulating Nucleic Acids in Plasma and Serum, Spain, 1 - 04 October 2011, pp.19

2011

2011

Genotoksik stres ilintili apoptozda kodlanmayan RNA analizi

Özgür E., Mert U., IŞIN M., DALAY M. N. , GEZER U.

XII. Tıbbi Biyoloji ve Genetik Kongresi, Antalya, Turkey, 1 - 04 October 2011

2011

2011

Genotoksik stres varlığında genomda global DNA metillenme düzeyinin incelenmesi

GEZER U., Özgür E., DALAY M. N.

IX. Ulusal Kanser Kongresi, Antalya, Turkey, 1 - 04 April 2011, pp.351

2009

2009

H3K9me3/H4K2Ome3 Ratio in Circulating Nucleosomes as Potential Biomarker for Colorectal Cancer

Deligezer U., Akisik E. Z. , Akisik E. E. , Kovancilar M., Bugra D., Erten N., et al.

6th International Conference on Circulating Nucleic Acids in Plasma and Serum, Hong Kong, PEOPLES R CHINA, 9 - 11 November 2009, pp.97-103 Sustainable Development identifier

2010

2010

Relevance of circulating nucleic acids with epigenetic changes in cancer

GEZER U.

IX Ulusal Tıbbi Genetik Kongresi, İstanbul, Turkey, 1 - 04 December 2010, pp.10 Sustainable Development

2010

2010

Histon modifications in circulating nucleosomes as potential biomarker in cancer

GEZER U., YÖRÜKER E. E. , Yılmaz E. Z. , Kovancılar M., Buğra D., Holdenrieder S., et al.

38th Meeting of the International Society of Oncology and Biomarkers (ISOBM), Germany, 1 - 04 September 2010, pp.34 Sustainable Development

2010

2010

CIRCULATING PLASMA BMP6 mRNA, CELL-FREE DNA, NUCLEOSOMES AND H3K27 METHYLATION LEVELS IN PROSTATE CANCER

Deligezer U., Yaman F., Darendeliler E., Dizdar Y., Holdenrieder S., Kovancilar M., et al.

38th Meeting of the International-Society-of-Oncology-and-BioMarkers (ISOBM), Munchen, Germany, 3 - 08 September 2010, vol.31 Sustainable Development identifier

2010

2010

HISTONE MODIFICATIONS H3K9ME3 AND H4K20ME3 ON CIRCULATING NUCLEOSOMES IN CANCER DISEASE

Leszinski G., Deligezer U., Siegele B., Holdenrieder S.

38th Meeting of the International-Society-of-Oncology-and-BioMarkers (ISOBM), Munchen, Germany, 3 - 08 September 2010, vol.31 Sustainable Development identifier

2010

2010

HISTON MODIFICATIONS IN CIRCULATING NUCLEOSOMES AS POTENTIAL BIOMARKER IN CANCER

Deligezer U., Akisik E. Z. , Akisik E. E. , Kovancilar M., Bugra D., Erten N., et al.

38th Meeting of the International-Society-of-Oncology-and-BioMarkers (ISOBM), Munchen, Germany, 3 - 08 September 2010, vol.31 Sustainable Development identifier

2009

2009

H3K9me3/H4K20me3 ratio on circulating nucleosomes as potential biomarker for colorectal cancer

GEZER U., Akışık E. Z. , AKIŞIK E. E. , Kovancılar M., Buğra D., ERTEN S. N. , et al.

6th International Conference on Circulating Nucleic Acids in Plasma and Serum, Hong Kong, 1 - 04 November 2009 Sustainable Development

2008

2008

Detection of Histone Methylation On Circulating Nuclesomes In Blood Plasma

GEZER U., YÖRÜKER E. E. , Erten S., DALAY M. N.

ASCO Annual Meeting, United States Of America, 1 - 04 June 2008, pp.14590

2008

2008

Kan plazmasında serbest nükleozom ve DNA arasındaki kantitatif ilişkinin incelenmesi.

GEZER U., AKIŞIK E. E. , ERTEN S. N. , DALAY M. N.

VIII. Ulusal Tıbbi Genetik Kongresi, Çanakkale, Turkey, 1 - 04 May 2008, pp.204

2007

2007

Plazma DNA bütünlüğünün kanserde biyomarker potansiyeli

GEZER U., AKIŞIK E. E. , ERTEN S. N. , DALAY M. N.

XVII. Ulusal Kanser Kongresi, Antalya, Turkey, 1 - 04 April 2007, pp.193-194 Sustainable Development

2006

2006

Lösemili hastaların mononükleer hücrelerinde TRAİL reseptör ekspresyonu

GEZER U., DALAY M. N.

VII. Prenatal Tanı ve Tıbbi Genetik Kongresi, Kayseri, Turkey, 1 - 04 April 2006, pp.105

2005

2005

Methylation of p16INK4A gene in plasma of patients with multiple myeloma

GEZER U., AKIŞIK E. E. , DALAY M. N.

Symposium on Circulating Nucleic Acids in Plasm/Serum-IV, United Kingdom, 1 - 04 September 2005, pp.12

2003

2003

Türk meme kanserli hastalarda XRCC1 gen polimorfizmi ve kanser riski ile ilişkisi

GEZER U., AKIŞIK E. E. , DALAY M. N.

8. Ulusal Tıbbi Biyoloji Kongresi, Adana, Turkey, 1 - 04 September 2003, pp.122 Sustainable Development

2003

2003

Lenfoma hastalarının plazmalarında metilenmiş DNA ve nükleozomal DNA

GEZER U., AĞAOĞLU F., ERTEN S. N. , DALAY M. N.

XV. Ulusal Kanser Kongresi, Antalya, Turkey, 1 - 04 April 2003, pp.186

2003

2003

HER2, estrogen receptor and methylenetetrahydrofolate gene polymorphisms in breast cancer.

Dalay N., Akisik E., Deligezer U.

26th Annual San Antonio Breast Cancer Symposium, San-Antonio, Northern Mariana Islands, 3 - 06 December 2003, vol.82 Sustainable Development identifier

Books & Book Chapters

2021

2021

Onkolojide Prediktif Biyobelirteçler

Özgür E., Gezer U.

in: Türkiye Klinikleri Klinisyenler İçin Temel Onkoloji, Aktaş Safiye,Alakavuklar Mehmet, Editor, Türkiye Klinikleri Yayınevi, Ankara, pp.73-78, 2021

2018

2018

Ferroptosis

YÖRÜKER E. E. , GEZER U.

in: Apoptosis and Beyond: The Many Ways Cells Die, Radosevich J, Editor, John Wiley & Sons, West Sussex, UK , C, pp.129-144, 2018

2018

2018

Ferroptosis

YÖRÜKER E. E. , GEZER U.

in: Apoptosis and Beyond: The Many Ways Cells Die, Radosevich J, Editor, John Wiley & Sons, West Sussex, UK , C, pp.129-144, 2018

2018

2018

Ferroptosis

YÖRÜKER E. E. , GEZER U.

in: Apoptosis and Beyond: The Many Ways Cells Die, Radosevich J, Editor, John Wiley & Sons, West Sussex, UK , C, pp.129-144, 2018

2011

2011

H3K9me3/H4K20me3 Ratio in Circulating Nucleosomes as Potential Biomarker for Colorectal Cancer

GEZER U., YÖRÜKER E. E. , AKIŞIK E., KOVANCILAR M., BUĞRA D., Holdenrieder S., et al.

in: Circulating Nucleic Acids in Plasma and Serum, Graham PB, Editor, Springer, London/Berlin , Amsterdam, pp.97-103, 2011

Supported Projects

2015 - 2017

2015 - 2017

Akciğer Kanserinde LYVE-1'in ÖnemiSustainable Development

Project Supported by Higher Education Institutions

DURANYILDIZ H. D. (Executive), SERİLMEZ M., OĞUZ SOYDİNÇ H., TAŞ F., GEZER U., KİZİR A.

2016 - 2016

2016 - 2016

Serbest nükleozomların mide kanseri, inflamasyon ve kontrol grubunda karşılaştırılmasıSustainable Development

Project Supported by Higher Education Institutions

YÖRÜKER E. E. (Executive), GEZER U.

2014 - 2014

2014 - 2014

Circulating microRNAs in patients with breast cancer during neoadjuvant chemotherapySustainable Development

Project Supported by Higher Education Institutions

GEZER U. (Executive)

2013 - 2014

2013 - 2014

DNA Hasar Ajanlarına Maruz Kalan Kültür Hücrelerinden Eksozom Salgılanmasının Karakterizasyonu

Project Supported by Higher Education Institutions

GEZER U. (Executive)

2013 - 2014

2013 - 2014

Histon Modifikasyonlarının ELISA-tabanlı Yöntemle Değerlendirilmesi

Project Supported by Higher Education Institutions

GEZER U. (Executive)

2012 - 2014

2012 - 2014

Gentoksisk Stres Oluşturulan Hücrelerde Uzun Kodlanmayan RNA Analizi

Project Supported by Higher Education Institutions

GEZER U. (Executive)

2012 - 2014

2012 - 2014

Genotoksik stres varlığında miR-34 ifadesinin incelenmesi

Project Supported by Higher Education Institutions

GEZER U. (Executive)

2012 - 2014

2012 - 2014

DNA Hasarı Oluşturulan Hücrelerde Uzun Kodlanmayan RNA Analizi

Project Supported by Higher Education Institutions

GEZER U. (Executive)

2012 - 2014

2012 - 2014

Prostat Kanserli Hastaların Plazmalarında mikroRNA-141 Molekülünün Klinik Yararlılığının AraştırılmasıSustainable Development

Project Supported by Higher Education Institutions

GEZER U. (Executive)

2011 - 2014

2011 - 2014

Plazmada RNA bütünlüğünün incelenmesi

Project Supported by Higher Education Institutions

GEZER U. (Executive)

2011 - 2013

2011 - 2013

Kan Plazmasında Histon Metillenme Değişimlerinin KOlorektal Kanseri Öneminin AraştırılmasıSustainable Development

Project Supported by Higher Education Institutions

GEZER U. (Executive)

2012 - 2012

2012 - 2012

High-throughput sequencing of H3K9me3- and H4K20me3-associated circulating nucleosomal DNA

Project Supported by Higher Education Institutions

GEZER U. (Executive)

2011 - 2012

2011 - 2012

Meme Kanserli Hastaların Plazmalarında mikroRNA AnaliziSustainable Development

Project Supported by Higher Education Institutions

GEZER U. (Executive)

2011 - 2012

2011 - 2012

Genotoksik stres ilişkili apoptozda miR-34 mikroRNA gen ailesi ve caveolin-1 gen ifadelerinin incelenmesi.

Project Supported by Higher Education Institutions

GEZER U. (Executive)

2011 - 2012

2011 - 2012

DNA Hasarı Oluşum Sürecinde Uzun Kodlanmayan RNA'ların İncelenmesi.

Project Supported by Higher Education Institutions

GEZER U. (Executive)

2011 - 2012

2011 - 2012

Kan Plazmasında Nükleozom Miktarı ile Histon Metillenme Düzeyinin Karşılaştırılması

Project Supported by Higher Education Institutions

GEZER U. (Executive)

2010 - 2011

2010 - 2011

Kolorektal Kanserli Hastalarin Plazmalarında Histon Metillenme AnaliziSustainable Development

Project Supported by Higher Education Institutions

GEZER U. (Executive)

2009 - 2011

2009 - 2011

Anti-Kanser Ajan Bleomisinin Yol Açtığı Genotoksik Stres ve Apoptozda DNA Metillenme ve mikroRNA AnaliziSustainable Development

Project Supported by Higher Education Institutions

GEZER U. (Executive)

2009 - 2011

2009 - 2011

Kan Plazmasında Histon Metillenme Düzeylerinin Optimize Edilmesi

Project Supported by Higher Education Institutions

GEZER U. (Executive)

2009 - 2011

2009 - 2011

Metastatik Prostat Kanserli Hastaların Plazmalarında mikroRNA AnaliziSustainable Development

Project Supported by Higher Education Institutions

GEZER U. (Executive)

2008 - 2011

2008 - 2011

Kolon Kanserli Hastaların Plazmalarında Histon Metilasyon AnaliziSustainable Development

Project Supported by Higher Education Institutions

GEZER U. (Executive)

2010 - 2010

2010 - 2010

HISTON MODIFICATIONS IN CIRCULATING NUCLEOSOMES AS POTENTIAL BIOMARKER IN CANCERSustainable Development

Project Supported by Higher Education Institutions

GEZER U. (Executive)

2009 - 2009

2009 - 2009

H3K9me3/H4K20me3 ratio on circulating nucleosomes as potential biomarker for colorectal cancerSustainable Development

Project Supported by Higher Education Institutions

GEZER U. (Executive)

2008 - 2009

2008 - 2009

Serum/Plazmada Histon Modifikasyonlarının Kanser Özgüllüğünün AraştırılmasıSustainable Development

Project Supported by Higher Education Institutions

GEZER U. (Executive)

2008 - 2009

2008 - 2009

Kan Plazmasında Serbest DNA Miktarı PCR'da Çoğaltılan Fragment Büyüklüğüne Göre Değişiyor mu?

Project Supported by Higher Education Institutions

GEZER U. (Executive)

2007 - 2009

2007 - 2009

Kanserli Hastaların Serumlarında Serbest DNA Bütünlüğünün Kantitatif Real-Time PCR ile İncelenmesiSustainable Development

Project Supported by Higher Education Institutions

GEZER U. (Executive)

Memberships / Tasks in Scientific Organizations

2009 - Continues

2009 - Continues

Tıbbi Biyoloji ve Genetik derneği

Member

Scientific Refereeing

September 2015

September 2015

TUBITAK Project

August 2015

August 2015

Clinical Genetics

National Scientific Refreed Journal

May 2015

May 2015

TUBITAK Project

April 2015

April 2015

Tumor Biology

SCI Journal

March 2013

March 2013

Clinica Chimica Acta

SCI Journal

March 2013

March 2013

Clinical Biochmeistry

SCI Journal

February 2013

February 2013

Tumor Biology

SCI Journal

December 2012

December 2012

Tumor Biology

SCI Journal

July 2012

July 2012

Clinica Chimica Acta

SCI Journal

May 2012

May 2012

Clinica Chimica Acta

SCI Journal

April 2012

April 2012

Clinical Biochemistry

SCI Journal

February 2012

February 2012

Clinica Chimica Acta

SCI Journal

January 2012

January 2012

Clinica Chimica Acta

SCI Journal

June 2011

June 2011

Clinica Chimica Acta

SCI Journal

February 2011

February 2011

BMC Cancer

SCI Journal

Scientific Consultations

2013 - 2015

2013 - 2015

Project Consultancy

TÜBİTAK

Istanbul University, Onkoloji Enstitüsü, Onkoloji, Turkey

2012 - 2015

2012 - 2015

Project Consultancy

PADOVA Universitesi

Istanbul University, Onkoloji Enstitüsü, Onkoloji, Turkey

2010 - 2015

2010 - 2015

Project Consultancy

TÜBİTAK

Istanbul University, Onkoloji Enstitüsü, Onkoloji, Turkey



Congress and Symposium Activities

01 October 2015 - 01 October 2015

01 October 2015 - 01 October 2015

Circulating nucleic acids in serum and plasma

Attendee

Berlin-Germany

01 September 2014 - 01 September 2014

01 September 2014 - 01 September 2014

Congress of Anticancer Research

Attendee

Thessaloníki-Greece

01 March 2014 - 01 March 2014

01 March 2014 - 01 March 2014

41h Congress of International Society of Oncology and Biomarkers

Attendee

Barcelona-Spain

01 October 2012 - 01 October 2012

01 October 2012 - 01 October 2012

. 40th Congress of International Society of Oncology and Biomarkers

Attendee

Yerushalayim-Israel

01 October 2011 - 01 October 2011

01 October 2011 - 01 October 2011

7th International Conference on Circulating Nucleic Acids in Plasma and Serum

Attendee

Madrid-Spain

01 October 2010 - 01 October 2010

01 October 2010 - 01 October 2010

38th Congress of International Society of Oncology and Biomarkers

Attendee

München-Germany

01 November 2009 - 01 November 2009

01 November 2009 - 01 November 2009

6th International Conference on Circulating Nucleic Acids in Plasma and Serum

Attendee

-Hong Kong

01 April 2009 - 01 April 2009

01 April 2009 - 01 April 2009

AACR Annual Meeting

Attendee

Colorado-United States Of America

01 August 2007 - 01 August 2007

01 August 2007 - 01 August 2007

Symposium on Circulating Nucleic Acids in Plasma Serum-V

Attendee

Moskva-Russia

Citations

Total Citations (WOS): 1678

h-index (WOS): 20